BIOMAT Database Logo BIOMAT Database Logo

Discovery of mixed type thymidine phosphorylase inhibitors endowed with antiangiogenic properties: synthesis, pharmacological evaluation and molecular docking study of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones. Part II. 2014

Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Gokaraju Rangaraju College of Pharmacy, Bachupally, Hyderabad 500090, India; Department of Pharmacy, Faculty of Science, National University of Singapore, 18 Science Drive 4, Singapore 117543, Singapore. Electronic address: hriday.bera1@gmail.com.

In our drug discovery program, a series of 2-thioxo-pyrazolo[1,5-a][1,3,5]triazin-4-ones were designed, synthesized and evaluated for their TP inhibitory potential. All the synthesized analogues conferred a varying degree of TP inhibitory activity, comparable or better than positive control, 7-deazaxanthine (7-DX, 2) (IC50 value = 42.63 μM). A systematic approach to the lead optimization identified compounds 3c and 4a as the most promising TP inhibitors, exhibiting mixed mode of enzyme inhibition. Moreover, selected compounds demonstrated the ability to attenuate the expression of the angiogenic markers (viz. MMP-9 and VEGF) in MDA-MB-231 cells at sublethal concentrations. In addition, molecular docking studies revealed the plausible binding orientation of these inhibitors towards TP, which was in accordance with the experimental results. Taken as a whole, these compounds would constitute a new direction for the design of novel TP inhibitors with promising antiangiogenic properties.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013457 Sulfur Compounds Inorganic or organic compounds that contain sulfur as an integral part of the molecule. Sulfur Compound,Compound, Sulfur,Compounds, Sulfur
D013939 Thymidine Phosphorylase An enzyme that catalyzes the transfer of 2-deoxy-D-ribose from THYMIDINE to orthophosphate, thereby liberating thymidine. PD-ECGF,Platelet-Derived Endothelial Cell Growth Factor,Gliostatin,Platelet Derived Endothelial Cell Growth Factor
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines

Related Publications

Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Synthesis, anti-thymidine phosphorylase activity and molecular docking of 5-thioxo-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-ones.
October 2013, Bioorganic chemistry,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Synthesis of pyrazolo[1,5-a][1,3,5]triazine derivatives as inhibitors of thymidine phosphorylase.
July 2013, European journal of medicinal chemistry,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Synthesis of substituted 4(6)-amino-1,3,5-triazin-2-ones and -1,3,5-triazin-2-thiones.
October 2001, The Journal of organic chemistry,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors.
November 2019, Bioorganic chemistry,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B.
September 2011, European journal of medicinal chemistry,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Synthesis and in vitro evaluation of 1,2,4-triazolo[1,5-a][1,3,5]triazine derivatives as thymidine phosphorylase inhibitors.
September 2013, Chemical biology & drug design,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities.
September 2013, European journal of medicinal chemistry,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Polycyclic nitrogen heterocycles as potential thymidine phosphorylase inhibitors: synthesis, biological evaluation, and molecular docking study.
December 2022, Journal of enzyme inhibition and medicinal chemistry,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
Fragment-based approach to the design of 5-chlorouracil-linked-pyrazolo[1,5-a][1,3,5]triazines as thymidine phosphorylase inhibitors.
January 2013, European journal of medicinal chemistry,
Hriday Bera, and Probir kumar Ojha, and Bee Jen Tan, and Lingyi Sun, and Anton V Dolzhenko, and Wai-Keung Chui, and Gigi Ngar Chee Chiu
2-Arylquinazolin-4(3H)-ones: A novel class of thymidine phosphorylase inhibitors.
December 2015, Bioorganic chemistry,
Copied contents to your clipboard!